SCAP activators, short for SREBP cleavage-activating protein activators, belong to a class of molecules that play a crucial role in the regulation of lipid metabolism within cells. These compounds are essential components of the intricate cellular machinery responsible for maintaining lipid homeostasis. Lipids are fundamental biomolecules that serve as structural components of cell membranes, energy storage molecules, and are involved in various cellular processes. SCAP activators, through their influence on the SREBP (sterol regulatory element-binding protein) pathway, exert control over the synthesis and uptake of cholesterol and fatty acids, thus ensuring the maintenance of an optimal lipid balance in the body.
At the heart of SCAP activators' mechanism of action is their interaction with SCAP, a transmembrane protein localized in the endoplasmic reticulum (ER) membrane. SCAP serves as a molecular sensor for cellular cholesterol levels. When cholesterol levels are low, SCAP activators bind to SCAP, triggering a conformational change that enables the transport of SREBPs from the ER to the Golgi apparatus. Here, SREBPs undergo proteolytic processing to their active forms, which then translocate to the nucleus and activate genes responsible for cholesterol and fatty acid biosynthesis. In essence, SCAP activators act as molecular switches that coordinate cellular responses to fluctuating lipid levels, ensuring that cells can synthesize or acquire lipids as needed for their various functions. Understanding the precise mechanisms of SCAP activators is of paramount importance in the context of cellular biology and lipid metabolism research, shedding light on the intricate ways in which cells maintain lipid balance for their survival and functionality.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lanosterol | 79-63-0 | sc-215229 sc-215229A | 1 mg 5 mg | $105.00 $350.00 | 2 | |
Lanosterol is an intermediate compound in the cholesterol biosynthesis pathway. A decrease in lanosterol levels activates Scap, leading to increased SREBP-mediated cholesterol synthesis. | ||||||
Palmitoleic acid | 373-49-9 | sc-205424 sc-205424A sc-205424B sc-205424C sc-205424D | 100 mg 500 mg 1 g 5 g 10 g | $33.00 $135.00 $238.00 $1039.00 $1907.00 | 4 | |
Palmitoleic acid, an unsaturated fatty acid, can activate Scap by promoting its translocation to the Golgi apparatus. This activation results in increased lipid synthesis. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic acid, another unsaturated fatty acid, can stimulate Scap activity, contributing to SREBP-mediated lipid synthesis. | ||||||
Linoleic Acid | 60-33-3 | sc-200788 sc-200788A sc-200788B sc-200788C | 100 mg 1 g 5 g 25 g | $34.00 $64.00 $166.00 $281.00 | 4 | |
Linoleic acid, a polyunsaturated fatty acid, activates Scap and supports the SREBP pathway, leading to enhanced lipid synthesis. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Arachidonic acid, a polyunsaturated fatty acid, can activate Scap, thereby promoting SREBP-mediated lipid synthesis. | ||||||